Memorial Sloan Kettering Cancer Center

Join thoracic oncology experts from Memorial Sloan Kettering Cancer Center (MSK) this weekend at the NY Lung Cancers Symposium, including Dr. Helena Yu, Dr. Alexander Drilon, Dr. Gregory Riely, and more as they speak about the latest in lung cancer treatment and research. Learn more here: https://bit.ly/4ewpNZNCon

What's your risk of getting lung cancer if you're a woman who has never smoked? Dr. Helena Yu, a thoracic oncologist and early drug development specialist at Memorial Sloan Kettering Cancer Center (MSK), shares why #lungcancer is more common in women than men in the 35-to-54 age group and why people can get lung cancer even if they’ve never smoked. https://bit.ly/4ew1VWu

Interested in completing a PGY2 Pharmacy Residency at Memorial Sloan Kettering Cancer Center (MSK)? MSK will host virtual information sessions for PGY2 Pharmacy Residency Programs on Tuesday, 11/19. Learn more about MSK's pharmacy programs and have the opportunity to meet program directors. Register here: https://lnkd.in/e7YEc9yi

In a new paper published in Nature Magazine, researchers at Memorial Sloan Kettering Cancer Center (MSK) are demonstrating that cancer outcome predictions can be improved by breaking down hospitals’ traditional data silos with the help of artificial intelligence (#AI). Learn more: https://lnkd.in/gCXK828y

“We were improvising on the fly. His whole treatment was very much like jazz music.” Learn how expert pathologists at Memorial Sloan Kettering Cancer Center used genomic testing to cure a renowned musician's cancer and how his remarkable case has led to a new way to treat patients: https://bit.ly/3CluMPG

Staff Spotlight: Steve Bishun, a safety advisor at Memorial Sloan Kettering Cancer Center (MSK), joined the Navy in 2000 and was enlisted right before September 11, 2001. “I was just 20 years old, about to go on deployment and spending some time with my family,” Steve recalls. “Watching the second plane hit the Twin Towers, I just knew things were about to change. Within 24 hours, we deployed.” As a young sailor aboard an aircraft carrier, Steve was responsible for supporting troops in the Middle East. “At 20 years old, you have no idea what to expect, but serving my country gave me purpose and made me who I am today,” Steve says. Today, Steve works as a safety advisor where he oversees inspections, incident response, and safety assessments for construction projects. He feels his military background equipped him well for his role, “The Navy taught me discipline, punctuality, and the importance of following procedures,” Steve explains. “At MSK, we’re responsible for ensuring a safe environment for our patients and staff, which is always top of mind.” Steve is also inspired by MSK’s compassionate care on a personal level. His mother, a former MSK patient, benefited from the exceptional treatment MSK is known for. “Seeing how well my mom was cared for at MSK makes me even more dedicated and prouder to work here,” he says.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) are making strides in cancer care. New research from MSK marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; and more: https://bit.ly/4hXmIoT

In a new study published in Nature, Dr. Craig Thompson and his colleagues in the Cancer Biology and Genetics Program at the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK), answer a fundamental question about cell biology and how mitochondria function under stress, such as cancer. Learn more: https://bit.ly/4ex3uDo

New research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may be linked to some genetic mutations that drive specific subtypes of cancer. MSK thoracic medical oncologist Dr. Justin Jee and MSK computational oncologist Dr. Ed Reznik led a team of researchers who found that obesity is linked to driver mutations in tumors that result in specific subtypes of some cancers, including lung and endometrial cancer. “We now know that obesity is not only associated with the risk of developing cancer and the subsequent prognosis,” says Dr. Reznik. “It also shapes the kinds of mutations a tumor acquires, and thus the kinds of therapies that a patient may be eligible for.” Learn more: https://bit.ly/4eu8aKh

Memorial Sloan Kettering Cancer Center (MSK) commemorated the 15th anniversary of its Technology Development Fund (TDF) at a recent MSK Innovation with Lasting Impact event at the Mortimer B. Zuckerman Research Center. “The TDF has provided invaluable gap funding to our talented innovators, advancing close to 60 promising life sciences and digital health technologies, including two that went on to become FDA approved drugs,” said Yashodhara Dash, Vice President of Technology Management & Commercialization at MSK. “This support is essential to get MSK's high-quality innovations to a point where they can be successfully partnered and return value back to fund MSK's mission.” Learn more about innovation at MSK: https://bit.ly/3O3NA8F